期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Development of a Rapid Risk and Impact Assessment Tool to Enhance Response to Environmental Emergencies in the Early Stages of a Disaster: A Tool Developed by the European Multiple Environmental Threats Emergency NETwork (EMETNET) Project 被引量:3
1
作者 Emma-Jane Goode Eirian Thomas +10 位作者 Owen Landeg Raquel Duarte-Davidson Lisbeth Hall Jolanda Roelofs Sjors Schulpen Arnout De Bruin Elisabeth Wigenstam Birgitta Liljedahl Annica Waleij Louise simonsson Ann Göransson Nyberg 《International Journal of Disaster Risk Science》 SCIE CSCD 2021年第4期528-539,共12页
Every year,numerous environmental disasters and emergencies occur across the globe with far-reaching impacts on human health and the environment.The ability to rapidly assess an environmental emergency to mitigate pot... Every year,numerous environmental disasters and emergencies occur across the globe with far-reaching impacts on human health and the environment.The ability to rapidly assess an environmental emergency to mitigate potential risks and impacts is paramount.However,collating the necessary evidence in the early stages of an emergency to conduct a robust risk assessment is a major challenge.This article presents a methodology developed to help assess the risks and impacts during the early stages of such incidents,primarily to support the European Union Civil Protection Mechanism but also the wider global community in the response to environmental emergencies.An online rapid risk and impact assessment tool has also been developed to promote enhanced collaboration between experts who are working remotely,considering the impact of a disaster on the environment and public health in the short,medium,and long terms.The methodology developed can support the appropriate selection of experts and assets to be deployed to affected regions to ensure that potential public health and environmental risks and impacts are mitigated whenever possible.This methodology will aid defensible decision making,communication,planning,and risk management,and presents a harmonized understanding of the associated impacts of an environmental emergency. 展开更多
关键词 Civil protection Environmental emergencies Impact assessment Risk assessment Systematic expert judgment
原文传递
Insights into the present and future of cartilage regeneration and joint repair
2
作者 H.Evenbratt L.Andreasson +3 位作者 V.Bicknell M.Brittberg R.Mobini S.simonsson 《Cell Regeneration》 2022年第1期24-39,共16页
Knee osteoarthritis is the most common joint disease.It causes pain and suffering for affected patients and is the source of major economic costs for healthcare systems.Despite ongoing research,there is a lack of know... Knee osteoarthritis is the most common joint disease.It causes pain and suffering for affected patients and is the source of major economic costs for healthcare systems.Despite ongoing research,there is a lack of knowledge regarding disease mechanisms,biomarkers,and possible cures.Current treatments do not fulfill patients’long-term needs,and it often requires invasive surgical procedures with subsequent long periods of rehabilitation.Researchers and companies worldwide are working to find a suitable cell source to engineer or regenerate a functional and healthy articular cartilage tissue to implant in the damaged area.Potential cell sources to accomplish this goal include embryonic stem cells,mesenchymal stem cells,or induced pluripotent stem cells.The differentiation of stem cells into different tissue types is complex,and a suitable concentration range of specific growth factors is vital.The cellular microenvironment during early embryonic development provides crucial information regarding concentrations of signaling molecules and morphogen gradients as these are essential inducers for tissue development.Thus,morphogen gradients implemented in developmental protocols aimed to engineer functional cartilage tissue can potentially generate cells comparable to those within native cartilage.In this review,we have summarized the problems with current treatments,potential cell sources for cell therapy,reviewed the progress of new treatments within the regenerative cartilage field,and highlighted the importance of cell quality,characterization assays,and chemically defined protocols. 展开更多
关键词 Articular Cartilage OSTEOARTHRITIS Joint treatments Stem cell therapy Gradients DIFFERENTIATION Chondrocyte characterization
原文传递
溶酶体酸化可增强吞噬性星形胶质细胞的消化功能
3
作者 Kelly R.Monk M.Laura Feltri +5 位作者 Carla Taveggia Camilla Lv Claire H.Mitchell Martin simonsson Anna Erlandsson 唐颖馨 《神经损伤与功能重建》 2015年第5期425-425,共1页
低效的溶酶体降解是多种脑部疾病发展的中心环节,但其具体机制及参与的细胞种类仍不清楚。既往研究显示,星形胶质细胞大量吞噬死亡的细胞,但将这些吞噬的物质储存在细胞内而不是进行降解。本研究对星形胶质细胞降解消化功能减弱的原因... 低效的溶酶体降解是多种脑部疾病发展的中心环节,但其具体机制及参与的细胞种类仍不清楚。既往研究显示,星形胶质细胞大量吞噬死亡的细胞,但将这些吞噬的物质储存在细胞内而不是进行降解。本研究对星形胶质细胞降解消化功能减弱的原因进行研究,并探索增强星形胶质细胞降解消化功能的方法。结果显示,长期存在于吞噬泡周围的肌动环阻碍了溶酶体的吞噬溶解作用。此外,Rab27a蛋白可以通过Nox2减少溶酶体的酸化,而星形胶质细胞高表达Rab27a蛋白,阻碍抗原呈递。本研究还发现,Nox2与星形胶质细胞摄取的物质共定位,且表达主要组织相容性复合体II,提示这可能影响星形胶质细胞内的抗原呈递。使用酸化纳米粒子对星形胶质细胞溶酶体进行长时间的酸化处理,能增加星形胶质细胞对所摄取物质和死亡细胞的消化。但随着酸化时间的延长,星形胶质细胞的消化能力再次回复到较低水平,提示随着酸化作用的增强,细胞的对抗酸化的通路也相应增强了。 展开更多
关键词 Nox2 消化 星形胶质细胞 溶酶体 纳米粒子 pHrodo 染料 吞噬作用
下载PDF
甲氧苄啶-磺胺甲噁唑对包括多重耐药株在内的结核分枝杆菌的细胞内外抗菌活性研究
4
作者 Davies F L Schon T +1 位作者 simonsson U S 杨洋 《中国感染与化疗杂志》 CAS CSCD 北大核心 2015年第5期414-414,共1页
甲氧苄啶‐磺胺甲口恶唑(TMP‐SMX ,SXT)系磺胺类药物的复方制剂,两药的配比为1∶19。本研究进行SXT 对100株结核分枝杆菌(T B )的体外药敏试验。药敏试验采用固态Middlebrook 7H10培养基和对倍稀释法。SXT的浓度测试范围为0.008... 甲氧苄啶‐磺胺甲口恶唑(TMP‐SMX ,SXT)系磺胺类药物的复方制剂,两药的配比为1∶19。本研究进行SXT 对100株结核分枝杆菌(T B )的体外药敏试验。药敏试验采用固态Middlebrook 7H10培养基和对倍稀释法。SXT的浓度测试范围为0.008/0.15~8/152 mg/L。同时用液态Bactec 960 MGIT培养系统测试了17株 TB。100株受试菌株中包括14株敏感的野生型菌株(wild‐TB )、48株多重耐药菌株(MDR‐TB)和13株广泛耐药菌株(XDR‐TB ),以及其他各种耐药模式的菌株。试验结果显示,无论固态 Middlebrook 7H10培养基,还是液态Bactec 960 MGIT 培养系统测试均显示SXT对敏感菌株和 MDR‐TB、XDR‐TB菌株均有抑菌作用,SXT的最低抑菌浓度(MIC)均低于2/38 mg/L ,在敏感和耐药的两类菌株间没有差异。此结果支持先前有学者提出SXT 对 TB 的折点为2/38mg/L。应用发光法检测SXT中单药和联合时的生长抑制效应,结果显示SXT中对TB的有效组分为SMX ,TMP未显示协同作用。使用 THP 巨噬细胞模型研究 SMX 对敏感 TB 质控株 H37Rv (ATCC27294)的细胞内抗菌作用,显示在细胞内76 mg/L浓度的SMX可以抑制90%的敏感TB细胞数(MIC90为76 mg/L),但当SMX的浓度提高到120 mg/L时仍有少量敏感TB细胞存活,提示SXT对细胞外TB的作用优于细胞内TB的作用。运用蒙特卡洛模拟,若以 fAUC0‐24/MIC≥25为靶值,当SMX剂量超过2400 mg时累计反应百分率达到90%以上。综上所述,SXT 可以作为治疗 MDR /XDR‐TB的备选药物,但应该用于 TB感染的第1个月内,因为此时TB还位于细胞外。 展开更多
关键词 结核分枝杆菌 磺胺甲口恶唑 多重耐药株 甲氧苄啶 细胞内 抗菌活性 多重耐药菌株 最低抑菌浓度
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部